Infusion of high-dose sufentanil (6 micrograms/kg) was associated with 27 to 30% decreases in cerebral blood flow velocity compared to moderate doses of fentanyl or sufentanil (p < 0.05).
RCT (n=30)
Does sufentanil compared to fentanyl affect cerebral blood flow velocity in ASA II and III patients undergoing elective CABG?
High-dose sufentanil decreases cerebral blood flow velocity during anesthesia induction for CABG, whereas moderate doses of fentanyl or sufentanil do not alter it.
p-value: p=< 0.05
Our study investigated the effects of moderate doses of fentanyl and sufentanil versus high-dose sufentanil on cerebral hemodynamics by using transcranial Doppler ultrasonography (TCD). Thirty American Society of Anesthesiologists (ASA) II and III patients scheduled for elective coronary artery bypass graft (CABG) were studied after Institutional Review Board (IRB) approval and informed consent. The evening before surgery, all patients received oral flurazepam (1 mg/kg), Atropine (0.4 mg/70 kg s.c.) and a combination of droperidol (70 micrograms/kg s.c.) plus fentanyl (1.5 micrograms/kg s.c.) were given as preanesthetic medication 1 h before induction of anesthesia. Anesthesia was induced with either 25 micrograms/kg fentanyl i.v. (group 1, n = 10), 3 micrograms/kg sufentanil i.v. (group 2, n = 10) or 6 micrograms/kg sufentanil i.v. (group 3, n = 10). All patients received 100 micrograms/kg pancuronium i.v. With the induction of respiratory depression, assisted ventilation was performed followed by controlled ventilation to maintain normoxia and normocapnia (FiO2, 1.0). Cerebral blood flow velocity (CBFV, cm/s) was measured continuously in the middle cerebral artery by using a bidirectional 2-MHz TCD system. Monitoring included heart rate (HR, beats/min), direct mean arterial blood pressure (MAP, mm Hg), and PaCO2. Physiologic variables including arterial blood gases were measured at baseline, 5 min, and 10 min after infusion of fentanyl or sufentanil. In all patients, HR, MAP, end-tidal carbon dioxide tension (PetCO2), and PaCO2 were constant over time and did not differ between groups. CBFV did not change with moderate doses of fentanyl (group 1) or sufentanil (group 2). In contrast, infusion of high-dose sufentanil (group 3) was associated with 27 to 30% decreases in CBFV (p < 0.05). Our results suggest that sufentanil decreases CBFV in a dose-related fashion with a threshold effect. Increases in CBFV and CBF seen in previous studies may be related to an increasing PaCO2 when maintenance of normocarbia is based on only real-time capnography with a constant PetCo2 rather than additional arterial blood gas monitoring.
Werner et al. (1997) conducted an RCT in Elective coronary artery bypass graft (CABG) (n=30). High-dose sufentanil vs. Moderate doses of fentanyl (25 micrograms/kg i.v.) or sufentanil (3 micrograms/kg i.v.) was evaluated on Cerebral blood flow velocity (CBFV) (p=< 0.05). Infusion of high-dose sufentanil (6 micrograms/kg) was associated with 27 to 30% decreases in cerebral blood flow velocity compared to moderate doses of fentanyl or sufentanil (p < 0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: